BioNexus Gene Lab (BGLC) FCF Margin (2018 - 2026)
BioNexus Gene Lab (BGLC) reported FCF Margin of 647.91% for Q1 2026, down 60893.0% on a YoY basis from N/an in Q1 2025, and down 426.46% sequentially from 198.46% in Q4 2025.
BioNexus Gene Lab (BGLC) FCF Margin (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 9 years of FCF Margin data on file, last reported at 647.91% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 60893.0% year-over-year to 647.91%; the trailing twelve-month figure through Mar 2026 stood at 22.41% (up 1098.0% YoY), and the FY2025 full-year result was 25.26%, down 86.0% from the prior year.
- FCF Margin slipped to 647.91% in Q1 2026, from 198.46% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 198.46% in Q4 2025 to a low of 647.91% in Q1 2026.
- A 5-year average of 43.94% and a median of 7.94% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 18994 bps in 2025 and plunged 60893 bps in 2026, its largest moves.
- Tracing BGLC's FCF Margin over 5 years: stood at 1.23% in 2022, then plunged by 2699 bps to 34.47% in 2023, then soared by 125 bps to 8.53% in 2024, then surged by 2228 bps to 198.46% in 2025, then plunged by 426 bps to 647.91% in 2026.
- Business Quant data shows BGLC's FCF Margin at 647.91% in Q1 2026, 198.46% in Q4 2025, and 48.86% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 10.23% |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | 0.01% |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | 18.06% |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | 34.80% |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | -0.48% |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | -7.48% |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | - |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 5.84% |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | 7.73% |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | -647.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -647.91% |
| Dec 31, 2025 | 198.46% |
| Sep 30, 2025 | -48.86% |
| Jun 30, 2025 | -33.60% |
| Mar 31, 2025 | -38.98% |
| Dec 31, 2024 | 8.53% |
| Sep 30, 2024 | -68.52% |
| Jun 30, 2024 | -34.14% |
| Mar 31, 2024 | -2.48% |
| Dec 31, 2023 | -34.47% |
| Sep 30, 2023 | -39.40% |
| Jun 30, 2023 | -2.02% |
| Mar 31, 2023 | -5.48% |
| Dec 31, 2022 | -1.23% |
| Sep 30, 2022 | 13.30% |
| Jun 30, 2022 | -7.94% |
| Mar 31, 2022 | -2.31% |
| Dec 31, 2021 | 14.84% |
| Sep 30, 2021 | 8.82% |
| Jun 30, 2021 | -29.29% |